Compare LNSR & ECOR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | LNSR | ECOR |
|---|---|---|
| Founded | 2004 | 2005 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Medical Electronics | Biotechnology: Electromedical & Electrotherapeutic Apparatus |
| Sector | Health Care | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 106.6M | 85.6M |
| IPO Year | 2005 | 2018 |
| Metric | LNSR | ECOR |
|---|---|---|
| Price | $7.06 | $11.24 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 1 | 1 |
| Target Price | $10.00 | ★ $18.00 |
| AVG Volume (30 Days) | 70.5K | ★ 80.6K |
| Earning Date | 05-11-2026 | 05-06-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ N/A |
| EPS | ★ 0.61 | N/A |
| Revenue | ★ $58,435,000.00 | $32,032,000.00 |
| Revenue This Year | $10.06 | $33.60 |
| Revenue Next Year | $41.48 | $30.40 |
| P/E Ratio | $11.60 | ★ N/A |
| Revenue Growth | 9.24 | ★ 27.20 |
| 52 Week Low | $4.95 | $4.41 |
| 52 Week High | $12.94 | $12.70 |
| Indicator | LNSR | ECOR |
|---|---|---|
| Relative Strength Index (RSI) | 40.76 | 63.24 |
| Support Level | $5.17 | $5.70 |
| Resistance Level | $8.73 | N/A |
| Average True Range (ATR) | 0.35 | 0.68 |
| MACD | -0.17 | 0.10 |
| Stochastic Oscillator | 9.56 | 68.39 |
LENSAR Inc is a commercial-stage medical device company focused on designing, developing, and marketing a femtosecond laser system for the treatment of cataracts. The company Laser System incorporates a range of proprietary technologies designed to assist the surgeon in obtaining visual outcomes, efficiency, and reproducibility by providing imaging, simplified procedure planning, efficient design, and precision. Its product portfolio consists of the LENSAR Laser System with Streamline IV and IntelliAxis and its associated consumable components. Geographically, the company generates the majority of its revenue from the United States, followed by Europe, Asia (excluding South Korea), South Korea, and Other.
electroCore Inc is a bioelectronic technology company whose mission is to improve health and quality of life through non-invasive bioelectronic technologies. Its two commercial products are gammaCore non-invasive vagus nerve stimulation, or nVNS, and Quell Fibromyalgia, or Quell. It also sells Truvaga and TAC-STIM products, which are handheld, personal-use consumer products developed to promote general wellness and human performance. It operates in one segment: Bioelectronic Innovations. Geographically, it operates in the United States, the United Kingdom, Japan, and Other.